ORASURE TECHNOLOGIES INC
For the period ended Dec 31, 2023. Filed Mar 11, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Mar 11, 2024
OSUR$3.33-5.7%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Stockholders’ Equity
For the Years Ended December 31, 2023, 2022 and 2021
| Common Stock · AdditionalPaid-in Capital · AccumulatedOtherComprehensive Loss · Accumulated Deficit · Total | ||||||
|---|---|---|---|---|---|---|
| Shares · Amount | ||||||
| Balance at January 1, 2021 | 71,738 | $— | $505,123 | $(9,097) | $(97,455) | $398,571 |
| Common stock issued upon exercise of options | 33 | — | 246 | — | — | 246 |
| Vesting of restricted stock and performance stock units | 451 | — | — | — | — | — |
| Purchase and retirement of common shares | (153) | — | (2,113) | — | — | (2,113) |
| Stock-based compensation | — | — | 7,807 | — | — | 7,807 |
| Net loss | — | — | — | — | (22,998) | (22,998) |
| Currency translation adjustments | — | — | — | (894) | — | (894) |
| Unrealized loss on marketable securities | — | — | — | (86) | — | (86) |
| Balance at December 31, 2021 | 72,069 | $— | $511,063 | $(10,077) | $(120,453) | $380,533 |
| Common stock issued upon exercise of options | 2 | — | 15 | — | — | 15 |
| Vesting of restricted stock and performance stock units | 992 | — | — | — | — | — |
| Purchase and retirement of common shares | (329) | — | (2,254) | — | — | (2,254) |
| Stock-based compensation | — | — | 11,622 | — | — | 11,622 |
| Net loss | — | — | — | — | (17,133) | (17,133) |
| Currency translation adjustments | — | — | — | (8,572) | — | (8,572) |
| Unrealized gain on marketable securities | — | — | — | 214 | — | 214 |
| Balance at December 31, 2022 | 72,734 | $— | $520,446 | $(18,435) | $(137,586) | $364,425 |
| Common stock issued upon exercise of options | 44 | — | 269 | — | — | 269 |
| Vesting of restricted stock and performance stock units | 1,098 | — | — | — | — | — |
| Purchase and retirement of common shares | (348) | — | (1,901) | — | — | (1,901) |
| Stock-based compensation | — | — | 10,729 | — | — | 10,729 |
| Net income | — | — | — | — | 53,655 | 53,655 |
| Currency translation adjustments | — | — | — | 3,274 | — | 3,274 |
| Unrealized gain on marketable securities | — | — | — | 220 | — | 220 |
| Balance at December 31, 2023 | 73,528 | $— | $529,543 | $(14,941) | $(83,931) | $430,671 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.